GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation

Documenti analoghi

• Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression
  di: Muhammad Tahir, et al.
  Pubblicazione: (2026)
• Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
  di: Tahmid Hussain, et al.
  Pubblicazione: (2026)
• GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs
  di: Jirawan Vienghirun, et al.
  Pubblicazione: (2026)
• Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
  di: Inyoung Hwang, et al.
  Pubblicazione: (2026)
• Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
  di: Roberta Scairati, et al.
  Pubblicazione: (2026)